Analysis Tools|
Allele Symbol Allele Name Allele ID |
Ccm2tm1.1Kwhi targeted mutation 1.1, Kevin Whitehead MGI:3817970 |
||||||||||||||||||||||||
| Summary |
5 genotypes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• phenotype is stated to be identical to that of Ccm2 Gt(RRG051)Byg homozygotes; however no data are presented
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• increased early mortality
|
|
• cerebral cavernous malformations develop as early as two months after tamoxifen treatment at 1 day of age
• most mice have lesions at 4 months and all mice at 6 months
• additional abnormalities include capillary telangiectasias, isolated caverns and multiple back to back caverns, thrombosis, hemorrhage, formation of secondary channels
• attenuation of endothelial cells in larger secondary channels but no gaps
|
|
• foot processes are missing
|
|
• cerebral cavernous malformations develop as early as two months after tamoxifen treatment at 1 day of age
• most mice have lesions at 4 months and all mice at 6 months
• additional abnormalities include capillary telangiectasias, isolated caverns and multiple back to back caverns, thrombosis, hemorrhage, formation of secondary channels
• attenuation of endothelial cells in larger secondary channels but no gaps
|
|
• foci of mononuclear inflammatory cells also seen
|
|
• foot processes are missing
|
|
• foci of mononuclear inflammatory cells also seen
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
| cerebral cavernous malformation 2 | DOID:0060670 |
OMIM:603284 |
J:173947 | |
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• no vasculature defects are observed during development
• homozygote mice are born at the expected ratios
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• mice die between E9-E10 from failed angiogenesis
|
|
• the first branchial arch artery of E8.5 embryos fail to form a proper lumen
|
|
• the second branchial arch artery of E8.5 embryos fail to form a proper lumen
|
|
• the third branchial arch artery of E8.5 embryos fail to form a proper lumen
|
|
• the caudal portion of the dorsal aorta becomes enlarged in 8.5 embryos
|
|
• the first branchial arch artery of E8.5 embryos fail to form a proper lumen
|
|
• the second branchial arch artery of E8.5 embryos fail to form a proper lumen
|
|
• the third branchial arch artery of E8.5 embryos fail to form a proper lumen
|
|
• adjacent portions of the aorta are also narrow and irregular
|
|
• the branchial arch arteries, the first essential angiogenic vessels, fail to form a stable lumen in E8.5 embryos
• the heart is not functionally connected with the vasculature, and circulation fails to initiate
|
|
• circulation is not established in E8.5 embryos
|
|
• the first branchial arch artery of E8.5 embryos fail to form a proper lumen
|
|
• the second branchial arch artery of E8.5 embryos fail to form a proper lumen
|
|
• the third branchial arch artery of E8.5 embryos fail to form a proper lumen
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• no vasculature defects are observed during development
• homozygote mice are born at the expected ratios
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/17/2024 MGI 6.24 |
|
|
|
||
